Regulation of myoblast differentiation by metabolic perturbations induced by metformin

Theodora Pavlidou, Marco Rosina, Claudia Fuoco, Giulia Gerini, Cesare Gargioli, Luisa Castagnoli, Gianni Cesareni

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The metabolic perturbation caused by calorie restriction enhances muscle repair by playing a critical role in regulating satellite cell availability and activity in the muscles of young and old mice. To clarify the underlying mechanisms we asked whether myoblast replication and differentiation are affected by metformin, a calorie restriction-mimicking drug. C2C12, a mouse myoblast cell line, readily differentiate in vitro and fuse to form myotubes. However, when incubated with metformin, C2C12 slow their replication and do not differentiate. Interestingly, lower doses of metformin promote myogenic differentiation. We observe that metformin treatment modulates the expression of cyclins and cyclin inhibitors thereby inducing a cell cycle perturbation that causes a delay in the G2/M transition. The effect of metformin treatment is reversible since after drug withdrawal, myoblasts can re-enter the cell cycle and/or differentiate, depending on culture conditions. Myoblasts cultured under metformin treatment fail to up-regulate MyoD and p21cip1, a key step in cell cycle exit and terminal differentiation. Although the details of the molecular mechanisms underlying the effect of the drug on myoblasts still need to be clarified, we propose that metformin negatively affects myogenic differentiation by inhibiting irreversible exit from the cell cycle through reduction of MyoD and p21cip1 levels.

Original languageEnglish
Article numbere0182475
JournalPLoS One
Volume12
Issue number8
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

metformin
myoblasts
Myoblasts
Metformin
Cells
cell cycle
Cell Cycle
Cyclins
cyclins
drugs
Muscle
Pharmaceutical Preparations
Muscles
muscles
Skeletal Muscle Fibers
mice
Electric fuses
Cell culture
Repair
Up-Regulation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Pavlidou, T., Rosina, M., Fuoco, C., Gerini, G., Gargioli, C., Castagnoli, L., & Cesareni, G. (2017). Regulation of myoblast differentiation by metabolic perturbations induced by metformin. PLoS One, 12(8), [e0182475]. https://doi.org/10.1371/journal.pone.0182475

Regulation of myoblast differentiation by metabolic perturbations induced by metformin. / Pavlidou, Theodora; Rosina, Marco; Fuoco, Claudia; Gerini, Giulia; Gargioli, Cesare; Castagnoli, Luisa; Cesareni, Gianni.

In: PLoS One, Vol. 12, No. 8, e0182475, 01.08.2017.

Research output: Contribution to journalArticle

Pavlidou, T, Rosina, M, Fuoco, C, Gerini, G, Gargioli, C, Castagnoli, L & Cesareni, G 2017, 'Regulation of myoblast differentiation by metabolic perturbations induced by metformin', PLoS One, vol. 12, no. 8, e0182475. https://doi.org/10.1371/journal.pone.0182475
Pavlidou T, Rosina M, Fuoco C, Gerini G, Gargioli C, Castagnoli L et al. Regulation of myoblast differentiation by metabolic perturbations induced by metformin. PLoS One. 2017 Aug 1;12(8). e0182475. https://doi.org/10.1371/journal.pone.0182475
Pavlidou, Theodora ; Rosina, Marco ; Fuoco, Claudia ; Gerini, Giulia ; Gargioli, Cesare ; Castagnoli, Luisa ; Cesareni, Gianni. / Regulation of myoblast differentiation by metabolic perturbations induced by metformin. In: PLoS One. 2017 ; Vol. 12, No. 8.
@article{8ed2ef06af2b464ba619085eb6fa1db0,
title = "Regulation of myoblast differentiation by metabolic perturbations induced by metformin",
abstract = "The metabolic perturbation caused by calorie restriction enhances muscle repair by playing a critical role in regulating satellite cell availability and activity in the muscles of young and old mice. To clarify the underlying mechanisms we asked whether myoblast replication and differentiation are affected by metformin, a calorie restriction-mimicking drug. C2C12, a mouse myoblast cell line, readily differentiate in vitro and fuse to form myotubes. However, when incubated with metformin, C2C12 slow their replication and do not differentiate. Interestingly, lower doses of metformin promote myogenic differentiation. We observe that metformin treatment modulates the expression of cyclins and cyclin inhibitors thereby inducing a cell cycle perturbation that causes a delay in the G2/M transition. The effect of metformin treatment is reversible since after drug withdrawal, myoblasts can re-enter the cell cycle and/or differentiate, depending on culture conditions. Myoblasts cultured under metformin treatment fail to up-regulate MyoD and p21cip1, a key step in cell cycle exit and terminal differentiation. Although the details of the molecular mechanisms underlying the effect of the drug on myoblasts still need to be clarified, we propose that metformin negatively affects myogenic differentiation by inhibiting irreversible exit from the cell cycle through reduction of MyoD and p21cip1 levels.",
author = "Theodora Pavlidou and Marco Rosina and Claudia Fuoco and Giulia Gerini and Cesare Gargioli and Luisa Castagnoli and Gianni Cesareni",
year = "2017",
month = "8",
day = "1",
doi = "10.1371/journal.pone.0182475",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Regulation of myoblast differentiation by metabolic perturbations induced by metformin

AU - Pavlidou, Theodora

AU - Rosina, Marco

AU - Fuoco, Claudia

AU - Gerini, Giulia

AU - Gargioli, Cesare

AU - Castagnoli, Luisa

AU - Cesareni, Gianni

PY - 2017/8/1

Y1 - 2017/8/1

N2 - The metabolic perturbation caused by calorie restriction enhances muscle repair by playing a critical role in regulating satellite cell availability and activity in the muscles of young and old mice. To clarify the underlying mechanisms we asked whether myoblast replication and differentiation are affected by metformin, a calorie restriction-mimicking drug. C2C12, a mouse myoblast cell line, readily differentiate in vitro and fuse to form myotubes. However, when incubated with metformin, C2C12 slow their replication and do not differentiate. Interestingly, lower doses of metformin promote myogenic differentiation. We observe that metformin treatment modulates the expression of cyclins and cyclin inhibitors thereby inducing a cell cycle perturbation that causes a delay in the G2/M transition. The effect of metformin treatment is reversible since after drug withdrawal, myoblasts can re-enter the cell cycle and/or differentiate, depending on culture conditions. Myoblasts cultured under metformin treatment fail to up-regulate MyoD and p21cip1, a key step in cell cycle exit and terminal differentiation. Although the details of the molecular mechanisms underlying the effect of the drug on myoblasts still need to be clarified, we propose that metformin negatively affects myogenic differentiation by inhibiting irreversible exit from the cell cycle through reduction of MyoD and p21cip1 levels.

AB - The metabolic perturbation caused by calorie restriction enhances muscle repair by playing a critical role in regulating satellite cell availability and activity in the muscles of young and old mice. To clarify the underlying mechanisms we asked whether myoblast replication and differentiation are affected by metformin, a calorie restriction-mimicking drug. C2C12, a mouse myoblast cell line, readily differentiate in vitro and fuse to form myotubes. However, when incubated with metformin, C2C12 slow their replication and do not differentiate. Interestingly, lower doses of metformin promote myogenic differentiation. We observe that metformin treatment modulates the expression of cyclins and cyclin inhibitors thereby inducing a cell cycle perturbation that causes a delay in the G2/M transition. The effect of metformin treatment is reversible since after drug withdrawal, myoblasts can re-enter the cell cycle and/or differentiate, depending on culture conditions. Myoblasts cultured under metformin treatment fail to up-regulate MyoD and p21cip1, a key step in cell cycle exit and terminal differentiation. Although the details of the molecular mechanisms underlying the effect of the drug on myoblasts still need to be clarified, we propose that metformin negatively affects myogenic differentiation by inhibiting irreversible exit from the cell cycle through reduction of MyoD and p21cip1 levels.

UR - http://www.scopus.com/inward/record.url?scp=85029157275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029157275&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0182475

DO - 10.1371/journal.pone.0182475

M3 - Article

C2 - 28859084

AN - SCOPUS:85029157275

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e0182475

ER -